PHARMACIE PASTEUR MAGNEZ SELAS is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in WAZIERS (59119),
this company of category PME
shows in 2022 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PASTEUR MAGNEZ SELAS (SIREN 484920756)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
N/C
N/C
2 091 555 €
1 718 582 €
1 621 929 €
1 640 713 €
1 749 026 €
1 577 057 €
1 565 595 €
1 568 780 €
1 670 493 €
Net income
108 059 €
103 913 €
163 230 €
127 030 €
81 963 €
107 742 €
116 899 €
105 043 €
94 537 €
95 777 €
140 689 €
EBITDA
N/C
N/C
217 212 €
175 087 €
113 425 €
147 261 €
160 838 €
144 263 €
128 249 €
142 357 €
174 837 €
Net margin
N/C
N/C
7.8%
7.4%
5.1%
6.6%
6.7%
6.7%
6.0%
6.1%
8.4%
Revenue and income statement
In 2024, PHARMACIE PASTEUR MAGNEZ SELAS generates positive net income of 108 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2014-2024: 141 k€ -> 108 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
108 059 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 81%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
6.335%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.235%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
55.422
43.002
28.673
16.323
14.469
11.347
6.956
6.374
6.282
5.991
6.335
Financial autonomy
54.913
59.069
67.544
72.889
75.38
78.477
81.356
81.766
79.6
79.814
81.235
Repayment capacity
4.094
3.827
3.04
1.658
1.464
1.365
1.139
0.762
0.573
None
None
Cash flow / Revenue
7.235%
7.082%
6.525%
7.42%
7.373%
7.161%
5.603%
7.88%
8.018%
None%
None%
Sector positioning
Debt ratio
6.332024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of PHARMACIE PASTEUR MAGNEZ ... (6.33) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.23%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE PASTEUR MAGNEZ ... (81.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.57 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE PASTEUR MAGNEZ ... (0.57) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 211.35. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
80.365
96.525
84.882
79.703
129.582
168.125
178.221
223.869
176.298
206.401
211.349
Interest coverage
8.968
8.472
4.893
2.149
0.19
0.051
0.085
0.031
0.002
None
None
Sector positioning
Liquidity ratio
211.352024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+20 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE PASTEUR MAGNEZ ... (211.35) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.0x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE PASTEUR MAGNEZ ... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PASTEUR MAGNEZ SELAS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
94 633 €
131 903 €
100 887 €
92 526 €
162 834 €
227 813 €
209 310 €
231 768 €
253 601 €
0 €
0 €
Inventory turnover (days)
22
24
20
24
27
29
28
18
17
0
0
Customer payment term (days)
3
4
3
4
4
4
4
7
3
0
0
Supplier payment term (days)
51
64
50
59
49
51
57
53
52
0
0
Positioning of PHARMACIE PASTEUR MAGNEZ SELAS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE PASTEUR MAGNEZ SELAS is estimated at
1 508 583 €
(range 1 050 553€ - 2 256 927€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1050k€1508k€2256k€
1 508 583 €Range: 1 050 553€ - 2 256 927€
NAF 5 année 2024
Valuation method used
Net Income Multiple
108 059 €
×
14.0x
=1 508 584 €
Range: 1 050 554€ - 2 256 927€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PASTEUR MAGNEZ SELAS with other companies in the same sector:
Frequently asked questions about PHARMACIE PASTEUR MAGNEZ SELAS
What is the revenue of PHARMACIE PASTEUR MAGNEZ SELAS ?
The revenue of PHARMACIE PASTEUR MAGNEZ SELAS in 2022 is 2.1 M€.
Is PHARMACIE PASTEUR MAGNEZ SELAS profitable?
Yes, PHARMACIE PASTEUR MAGNEZ SELAS generated a net profit of 108 k€ in 2024.
Where is the headquarters of PHARMACIE PASTEUR MAGNEZ SELAS ?
The headquarters of PHARMACIE PASTEUR MAGNEZ SELAS is located in WAZIERS (59119), in the department Nord.
Where to find the tax return of PHARMACIE PASTEUR MAGNEZ SELAS ?
The tax return of PHARMACIE PASTEUR MAGNEZ SELAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PASTEUR MAGNEZ SELAS operate?
PHARMACIE PASTEUR MAGNEZ SELAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart